The Lancet (2021) This Phase 2 dose-finding trial randomized adults with overweight or obesity without diabetes to cagrilintide at doses from 0.3 to 4.5 mg weekly, placebo, or liraglutide 3.0 mg daily as an active comparator across 57 sites in 10 countries
70 In fact, researchers couldnt establish a clear LD (lethal dose) in animals because even extremely high doses didnt kill the subjects
The tradeoff is potentially more intense initial side effects, including more pronounced GI challenges and fatigue , but a shorter total duration of those effects
Each of these medications has undergone extensive review by the FDA, ensuring consistent dosing and safety validated by extensive clinical trials, and is designed to enhance weight loss efforts
In addition, semaglutide-induced restoration of circulating NK cell cytokine production has recently been proposed as a GLP1R-dependent immune regulatory mechanism improving metabolic outcomes in obesity and reduce cancer risk 92